abiraterone,olaparib
astrazeneca,merck
['prostate', 'crpc', 'pcsm', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
my goodness! a new doublet option in mcrpc #prostatecancer - parpi plus nht, by noel clarke #gu23 . overall survival benefit of 7mo very high in this setting. new standard of care? #pcsm 
Radiation Oncologist at the Peter MacCallum Cancer Centre @petermaccc, Associate Professor University of Melbourne, Australia 🇦🇺. Views are my own. #radonc